Literature DB >> 15862208

Magnetic resonance imaging at microscopic resolution reveals subtle morphological changes in a mouse model of dopaminergic hyperfunction.

Michel Cyr1, Marc G Caron, G Allan Johnson, Aki Laakso.   

Abstract

Structural abnormalities of the basal ganglia have been documented in several neuropsychiatric conditions associated with dysregulation of the dopamine system. However, the histological nature underlying these changes is largely unknown. Using magnetic resonance imaging at microscopic resolution (MRI, 9.4 T with 43 microm isotropic spatial resolution) and stereological techniques, we have investigated the effect of increased dopamine neurotransmission on brain morphology in mice with elevated extracellular dopamine, the dopamine transporter knockout (DAT-KO) mice. We first demonstrate the usefulness of MRI at microscopic resolution for the accurate identification and measurement of volumes of specific subregions, accounting for less than 0.03% (0.16 mm(3)) of the volume of a mouse brain. Furthermore, the MRI analysis reveals a significantly lower volume (-9%) of the anterior striatum of DAT-KO mice, while the volume of other dopamine-related structures such as the posterior striatum and the substantia nigra pars reticulata is unchanged in comparison to wild type littermates. Stereological analysis performed in the same brains reveals that one important structural factor accounting for this selective change in volume is a reduction of 18% in the absolute number of neuronal cell bodies. The feasibility of assessing accurately small morphological alterations in mouse models, where the molecular and histological pathologies can be easily compared in a controlled manner, provides a paradigm to examine the relevance of selective brain volumetric changes associated with a number of neuropathological conditions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15862208     DOI: 10.1016/j.neuroimage.2005.01.039

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  24 in total

1.  Genetic NMDA receptor deficiency disrupts acute and chronic effects of cocaine but not amphetamine.

Authors:  Amy J Ramsey; Aki Laakso; Michel Cyr; Tatyana D Sotnikova; Ali Salahpour; Ivan O Medvedev; Linda A Dykstra; Raul R Gainetdinov; Marc G Caron
Journal:  Neuropsychopharmacology       Date:  2008-01-09       Impact factor: 7.853

2.  Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease.

Authors:  Wenzhen Duan; Qi Peng; Naoki Masuda; Eric Ford; Erik Tryggestad; Bruce Ladenheim; Ming Zhao; Jean Lud Cadet; John Wong; Christopher A Ross
Journal:  Neurobiol Dis       Date:  2008-03-10       Impact factor: 5.996

3.  Striatal expression of a calmodulin fragment improved motor function, weight loss, and neuropathology in the R6/2 mouse model of Huntington's disease.

Authors:  Ying Dai; Nichole L Dudek; Qian Li; Stephen C Fowler; Nancy A Muma
Journal:  J Neurosci       Date:  2009-09-16       Impact factor: 6.167

4.  Bilirubin Links Heme Metabolism to Neuroprotection by Scavenging Superoxide.

Authors:  Chirag Vasavda; Ruchita Kothari; Adarsha P Malla; Robert Tokhunts; Anthony Lin; Ming Ji; Cristina Ricco; Risheng Xu; Harry G Saavedra; Juan I Sbodio; Adele M Snowman; Lauren Albacarys; Lynda Hester; Thomas W Sedlak; Bindu D Paul; Solomon H Snyder
Journal:  Cell Chem Biol       Date:  2019-07-25       Impact factor: 8.116

Review 5.  Behavioral and Neuroanatomical Phenotypes in Mouse Models of Autism.

Authors:  Jacob Ellegood; Jacqueline N Crawley
Journal:  Neurotherapeutics       Date:  2015-07       Impact factor: 7.620

6.  Neuroanatomical analysis of the BTBR mouse model of autism using magnetic resonance imaging and diffusion tensor imaging.

Authors:  Jacob Ellegood; Brooke A Babineau; R Mark Henkelman; Jason P Lerch; Jacqueline N Crawley
Journal:  Neuroimage       Date:  2012-12-26       Impact factor: 6.556

7.  Cystathionine γ-lyase deficiency mediates neurodegeneration in Huntington's disease.

Authors:  Bindu D Paul; Juan I Sbodio; Risheng Xu; M Scott Vandiver; Jiyoung Y Cha; Adele M Snowman; Solomon H Snyder
Journal:  Nature       Date:  2014-03-26       Impact factor: 49.962

8.  In vivo magnetic resonance imaging and semiautomated image analysis extend the brain phenotype for cdf/cdf mice.

Authors:  Nicholas A Bock; Natasa Kovacevic; Tatiana V Lipina; John C Roder; Susan L Ackerman; R Mark Henkelman
Journal:  J Neurosci       Date:  2006-04-26       Impact factor: 6.167

Review 9.  Dopamine transporter mutant animals: a translational perspective.

Authors:  Evgeniya V Efimova; Raul R Gainetdinov; Evgeny A Budygin; Tatyana D Sotnikova
Journal:  J Neurogenet       Date:  2016-03       Impact factor: 1.250

10.  Chronic HIV-1 Tat and HIV reduce Rbfox3/NeuN: evidence for sex-related effects.

Authors:  Yun Kyung Hahn; Ruturaj R Masvekar; Ruqiang Xu; Kurt F Hauser; Pamela E Knapp
Journal:  Curr HIV Res       Date:  2015       Impact factor: 1.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.